New treatment option for Antisocial Behavior
Official title Matching Treatments to Cognitive Deficits in Offenders With Substance Use Disorders
ClinicalTrials.gov ID: NCT06981351
What this study is testing
- What it's testing
- The goal of this clinical trial is to investigate the effect of two types of cognitive remediation training on real-world behavioral outcomes including substance use, institutional adjustment, and recidivism following release from prison. Each training type is designed to target one of two subtypes of antisocial criminal offenders, who are characterized by either: 1) Attention to context-based deficits, or 2) Affective cognitive control-based deficits.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55, men only
You may be able to join if
- Currently incarcerated
- No uncorrectable auditory or visual deficits
- Able to speak and/or understand English
- 5th grade reading level or higher
- IQ score = 80 or above
See the full eligibility criteria
- Currently incarcerated
- No uncorrectable auditory or visual deficits
- Able to speak and/or understand English
- 5th grade reading level or higher
- IQ score = 80 or above
- Lifetime history of substance use disorder based on DSM criteria
- No history of dementia or other cognitive disability
- No indication of current psychotic disorder
- No major medical illness or CNS disease
- Scores from the Psychopathy Checklist-Revised (PCL-R) meet criteria for one of the designated treatment groups
The study team makes the final eligibility decision.
Where it's taking place
- Albuquerque, New Mexico, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Albuquerque, New Mexico, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.